The Applied Behavior Analysis therapy industry generates approximately $4–5 billion in annual revenue in the United States, delivering intensive behavioral interventions to children and adults with autism spectrum disorder. The industry has grown dramatically over the past decade as state insurance mandates have expanded coverage for ABA therapy, driving demand for services that consistently exceeds the supply of qualified clinicians. The ABA market is one of the most actively consolidated sectors in healthcare services, with PE-backed behavioral health platforms, national autism services organizations, and health system partners acquiring practices aggressively to build geographic coverage and clinical capacity.

The primary valuation method for ABA practices is Seller's Discretionary Earnings, or SDE, for smaller practices transitioning to EBITDA for larger multi-site operations. SDE adds the owner's salary, personal benefits, and non-recurring costs back to net income. In ABA, the owner is often a BCBA who provides clinical services, and their clinical hours represent both personal compensation and revenue generation that must be carefully analyzed in the SDE calculation — if the owner-BCBA carries a full caseload, a portion of the practice's revenue is directly tied to their clinical labor. Common add-backs include the owner's total compensation, benefits, conference attendance, continuing education, vehicle expenses, and any above-market salaries to family members. ABA practices generally trade between 3.0x and 6.0x SDE, with the range driven by BCBA retention, billable hour utilization, payer diversification, RBT pipeline, patient census, and service delivery model. A practice at 3.0x SDE has high BCBA turnover, below-benchmark utilization, dependence on a single payer, difficulty recruiting RBTs, declining census, and the owner-BCBA carrying a large personal caseload. A practice at 6.0x retains 80%+ of BCBAs annually, achieves benchmark utilization, contracts with three or more major payers, has a reliable RBT pipeline, maintains a growing census with a waitlist, and operates with clinical directors managing services while the owner focuses on strategy.

Revenue multiples for ABA practices typically fall between 0.6x and 1.5x, reflecting the relatively strong margin profile of clinical services. Net margins in ABA range from 12% to 25% depending on clinician utilization, payer mix, and overhead efficiency. Revenue multiples should be evaluated alongside BCBA staffing metrics because revenue is directly tied to clinical capacity — the practice's current revenue level is only as sustainable as its ability to retain the clinicians generating that revenue.

For larger ABA operations generating $1M or more in annual EBITDA — typically multi-center practices with 20+ BCBAs — institutional buyers use EBITDA multiples in the 8x to 14x range. These premium multiples reflect the industry's extraordinary growth trajectory, the persistent supply-demand imbalance for ABA services, and the high barriers to building clinical capacity. PE-backed behavioral health platforms have invested billions in ABA acquisitions and continue to acquire aggressively. National autism services organizations build geographic coverage. Health systems acquire ABA practices to integrate developmental services into their care continuum.

The unique valuation factor in ABA therapy is the direct relationship between clinical headcount and revenue capacity — the practice's value is fundamentally a function of how many clinicians it employs and retains. Unlike most businesses where revenue can grow through pricing, marketing, or operational efficiency, ABA revenue is constrained by the number of BCBAs available to supervise treatment and the number of RBTs available to deliver direct therapy hours. Every BCBA supports a defined caseload generating a predictable revenue range, and every RBT delivers a calculable number of billable hours per week. This means that ABA practice valuation is essentially a per-clinician calculation multiplied by the probability that those clinicians will remain post-acquisition. A practice with 15 BCBAs at 85% retention is worth approximately 15 times the per-BCBA revenue capacity, discounted slightly for normal attrition. A practice with 15 BCBAs at 60% retention is worth significantly less because the buyer is modeling the replacement cost and revenue disruption of losing 6 BCBAs annually. This workforce-driven valuation dynamic means that every investment in BCBA retention — competitive compensation, manageable caseloads, clinical mentorship, career development — translates directly to business value. The BCBA who stays is worth $100K–$200K in additional business value at typical multiples, making retention investment the highest-ROI pre-sale activity in ABA.

The ABA M&A market is among the most active in healthcare services. PE-backed platforms continue to acquire aggressively to build national capacity. National autism services organizations pursue geographic expansion. Health systems add ABA to their service portfolios. Individual BCBAs acquiring practices for ownership are also active. For practices with strong BCBA retention, benchmark utilization, diversified payers, and reliable RBT pipelines, the market offers premium multiples and competitive bidding. Practices with clinical workforce challenges should focus on retention improvement and utilization optimization before pursuing a sale, as these metrics directly drive every dollar of valuation.

Use our free calculator above to get your instant estimate, then track your value monthly with YourExitValue.